Clinical Trials · NCT04102189
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 201
- Start date
- Oct 2019
- Locations
- 51 sites, 8 countries
- Primary endpoint
- Change in Body Mass Index (BMI) (Percentage [%])